|
|
||||||||
Journal of Lipid Research, Vol 32, 1889-1897, Copyright © 1991 by Lipid Research, Inc.
ARTICLES |
RI Grove, C Mazzucco, N Allegretto, PA Kiener, G Spitalny, SF Radka, M Shoyab, M Antonaccio and GA Warr
Oncogen, Bristol-Myers Squibb PRI, Seattle, WA 98121.
Recent evidence suggests the possibility that macrophages can influence lipoprotein metabolism. Therefore we investigated the ability of cultured macrophages to alter low density lipoprotein (LDL) uptake in a human liver cell line (HepG2). Conditioned media from phlogogenic- induced mouse peritoneal macrophages or from a human macrophage cell line stimulated with endotoxin increased HepG2 LDL uptake by as much as 60-70%. The increase was due, in part, to a significant macrophage- induced 40% increase in the number of LDL receptors per cell. Although macrophage conditioned media inhibited HepG2 cholesterol synthesis, the LDL receptor up-regulation did not appear to be due to the effects on cholesterol synthesis. The LDL receptor stimulatory activity was sensitive to proteolysis and heat. Its molecular mass was approximately 20 kDa based on gel filtration. Several macrophage secretory proteins were tested in HepG2 cultures for LDL uptake stimulation. Of these, oncostatin M (approximately 18 kDa by gel filtration) gave the strongest response. The rank order for LDL uptake stimulation was oncostatin M much greater than interleukin 6 = interleukin 1 = transforming growth factor-beta 1. A neutralizing antibody directed against oncostatin M inhibited the ability of conditioned media to up- regulate LDL receptors by 85%. Thus, our results indicate that macrophages can secrete several proteins that up-regulate LDL receptors in HepG2 cells and that most of the up-regulatory activity in macrophage conditioned media appears to be due to oncostatin M.
This article has been cited by other articles:
![]() |
P. J. Lafontant, A. R. Burns, E. Donnachie, S. B. Haudek, C. W. Smith, and M. L. Entman Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts Am J Physiol Cell Physiol, July 1, 2006; 291(1): C18 - C26. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, F. Zhang, C. Li, M. Lin, and M. R. Briggs Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 90 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Konno, K. A. Grindle, W.-M. Lee, M. K. Schroth, A. G. Mosser, R. A. Brockman-Schneider, W. W. Busse, and J. E. Gern Interferon-gamma Enhances Rhinovirus-Induced RANTES Secretion by Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 594 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Langmann, M. Porsch-Ozcurumez, S. Heimerl, M. Probst, C. Moehle, M. Taher, H. Borsukova, D. Kielar, W. E. Kaminski, E. Dittrich-Wengenroth, et al. Identification of Sterol-independent Regulatory Elements in the Human ATP-binding Cassette Transporter A1 Promoter. ROLE OF Sp1/3, E-BOX BINDING FACTORS, AND AN ONCOSTATIN M-RESPONSIVE ELEMENT J. Biol. Chem., April 19, 2002; 277(17): 14443 - 14450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, C. Li, T. E. Ahlborn, M. J. Spence, L. Meng, and L. M. Boxer The Expression of p53 Tumor Suppressor Gene in Breast Cancer Cells Is Down-Regulated by Cytokine Oncostatin M Cell Growth Differ., October 1, 1999; 10(10): 677 - 683. [Abstract] [Full Text] |
||||
![]() |
A. Kumar, A. Middleton, T. C. Chambers, and K. D. Mehta Differential Roles of Extracellular Signal-regulated Kinase-1/2 and p38MAPK in Interleukin-1beta - and Tumor Necrosis Factor-alpha -induced Low Density Lipoprotein Receptor Expression in HepG2 Cells J. Biol. Chem., June 19, 1998; 273(25): 15742 - 15748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, Y. L. Zhang, M. J. Spence, R. E. Vestal, P. M. Wallace, and D. S. Grass Liver LDL Receptor mRNA Expression Is Decreased in Human ApoB/CETP Double Transgenic Mice and Is Regulated by Diet as Well as the Cytokine Oncostatin M Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2948 - 2954. [Abstract] [Full Text] |
||||
![]() |
C. S. Moran, J. H. Campbell, and G. R. Campbell Human Leukemia Inhibitory Factor Upregulates LDL Receptors on Liver Cells and Decreases Serum Cholesterol in the Cholesterol-Fed Rabbit Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1267 - 1273. [Abstract] [Full Text] |
||||
![]() |
W. Liao, M. Rudling, and B. Angelin Novel Effects of Histamine on Lipoprotein Metabolism: Suppression of Hepatic Low Density Lipoprotein Receptor Expression and Reduction of Plasma High Density Lipoprotein Cholesterol in the Rat Endocrinology, May 1, 1997; 138(5): 1863 - 1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Hsu, A. C. Nicholson, K. B. Pomerantz, R. J. Kaner, and D. P. Hajjar Altered Cholesterol Trafficking in Herpesvirus-infected Arterial Cells J. Biol. Chem., August 18, 1995; 270(33): 19630 - 19637. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Moorby, E. Gherardi, D. Riddell, and D. E. Bowyer Porcine smooth muscle cell-conditioned medium stimulates LDL receptor activity in Hep G2 cells J. Cell Sci., October 1, 1992; 103(2): 541 - 549. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |